Authors
Latest:
The Top 5 Golden Opportunities for Pharma RecruitmentPharma companies must revise their recruitment strategies in the wake of a skills shortage.
Latest:
What Every Pharma CEO Should Know About Unlocking Scientific Data PotentialWhen integrated into pharmaceutical enterprises, scientific data has the potential to drive organizational growth and innovation. Mikael Hagstroem, CEO at leading laboratory informatics provider LabVantage Solutions, discusses how technology partners add significant value to pharmaceutical R&D, in addition to manufacturing quality.
Latest:
The EU Regulations Catching US Pharma Companies Off GuardCompanies that understand the regulatory environment in Europe can keep their trials on budget and on schedule.
Latest:
NFTs: What This New Kid on the Blockchain Means for HealthcareThere has been a push to implement NFTs, or non-fungible tokens, across many verticals, but there is still much to learn about their potential uses in healthcare and its brands.
Latest:
The Real Value of AI in Healthcare? Strengthening the Doctor-Patient RelationshipWhy empowering both parties with the tools and data they need to make clinical decisions should be a top priority in the AI renaissance—to bolster patient care and improve health outcomes.
Latest:
Elevating ESG Message: Today’s Modern Investor is KeyHow pharma companies can make sure their corporate strategy in ESG is appealing to younger generations—and aligns with the issues this large segment of sustainability investors care about most.
Latest:
The C-Suite’s Frontline Workers in Digital ChangeHow the CIO role has transformed and strengthened against the backdrop of COVID-19.
Latest:
Case Study: A Drug Launch into COVID HeadwindsLessons to launch by during a pandemic—or otherwise.
Latest:
How to Navigate Global Regulatory Hurdles to Successfully Launch a Medical DeviceManufacturers must navigate complex regulatory landscapes, understand diverse cultural nuances, and prioritize patient access in each region.
Latest:
A Look Back: The Life Sciences Industry in 2023 and a View for 2024In the coming year, efficiency and automation will take center stage to maximize constrained resources but balancing sensible financial management with strategic investments will be vital.
Latest:
The Role of AI in Digital TherapeuticsAI-enabled digital therapeutics have helped give new meaning to the term personalized medicine by tailoring not just the treatment itself, but the way that treatment is managed to the individual characteristics of each patient.
Latest:
Bridging the Data GapHow interoperability and clean data can harness the power of big data in pharma.
Latest:
As the Life Sciences Industry Transforms, New Risks EmergeLife sciences companies are collaborating more with technology enterprises, universities, and other groups, which is changing the landscape of the industry.
Latest:
Why Pharmaceutical Manufacturers Must Navigate Muddy Waters of ESG RequirementsRise in demand for sustainable practices forces industry to be more proactive.
Latest:
Blockchain, COVID-19 and the Pharmaceutical Supply ChainHannah Schofield and Lavan Thasarathakumar discuss what blockchain is, how it could help improve pharmaceutical supply chains, and the COVID-19 vaccine supply chain in particular, and touches on where we are already seeing blockchain technology being used in this area.
Latest:
How to Optimize ERP: Insights from Galera and Nabriva Therapeutics*** Wednesday, February 3, 2021 at 1pm EST | 12pm CST | 10am PST*** Industry leading ERP & MRP Solutions for Pharma. Join our informative Webinar with AdaptaLogix, the fastest growing NetSuite & Oracle partner, to learn more about the solutions that have been developed to meet mid-market pharma’s unmet needs. ***On demand available after final airing until Feb. 3, 2022***
Latest:
ROI and Rare Disease: Retooling the ‘Gene’ Value MachineFramework proposes three strategies designed to address the unique challenges of personalized and genetic therapies for rare diseases—and increase the probability of economic success for a new wave of potential curative treatments for these conditions.
Latest:
Why Program Management is the Key to Success for Life Science CompaniesDelivering value with enterprise program management.
Latest:
Building a Plan for Digital Transformation in Medical AffairsLeslie Rotz and Todd Parker outline four major steps in the Medical Affairs digital transformation journey.
Latest:
PREP Act Protections for COVID-19 Vaccine LiabilityHow PREP Act protections will apply to potential COVID-19 vaccine-related claims.
Latest:
Measuring Speaker Campaign EffectivenessSales and marketing effectiveness of speaker programs is often one of the least understood aspects in the industry. Yet, pharma brands spent over $12.5 billion in 2022 to engage and influence with HCP-to-HCP activities. CMS’s Open Payments data is an overlooked tool to get greater visibility and create more strategic opportunities—while also enriching compliance. This paper explores how to filter and pinpoint critical data sets using browser-based technology to gain marketing insights from this data and measure competitiveness.
Latest:
Navigating Disruption in the Metapharma EraAs the life sciences industry enters this next stage of growth, capitalizing on AI and digital transformation will be key to propelling innovation and ensuring that companies are prepared to tackle the challenges ahead.
Latest:
The Top Priority for Sales Leaders: Improving Sales Enablement and Training in PharmaAddressing key challenges in the modern sales sector requires a fundamental shift in training strategies.
Latest:
Fast-Tracking Development: How Life Sciences Will Drive Speed in 2025Biopharmas and global agencies are now prioritizing initiatives and innovations to drive speed across product development with an emphasis on getting new treatments in the hands of doctors and patients.
Latest:
Anchoring HEOR Evidence Generation in the Challenge from the MarketHEOR scientists in the pharma industry must balance methodologic rigor with commercial expectations and timelines.
